Trabectedin

Back to search

Molecule Structure

Scientific Name

Trabectedin

Description of the Drug

Trabectedin is an alkylating agent approved for the treatment of unresectable or metastatic soft tissue sarcoma (liposarcoma or leiomyosarcoma).

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB05109

Brand Name(s)

Yondelis

Company Owner(s)

Janssen Products Lp

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
DNA NUCLEIC-ACID INHIBITOR CHEMBL2311221

Unichem Links

SureChEMBL SCHEMBL12119916
PharmGKB PA165958349
Human Metabolome Database HMDB0015609
DrugBank DB05109
PubChem: Thomson Pharma 14938004 16067487
PubChem 108150
NMRShiftDB 70082190
Nikkaji J1.013.169C
PDBe ECT
EPA CompTox Dashboard DTXSID2046880
DrugCentral 4633
Metabolights MTBLC84050
ChemicalBook CB31364731
Guide to Pharmacology 2774
rxnorm TRABECTEDIN
PubChem: Drugs of the Future 12014180
ChEBI 84050
ZINC ZINC000150338708